Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study.
Carlomagno C, Lauria R, De Laurentiis M, Arpino G, Massarelli E, Ferrara C, Milano A, Vernaglia Lombardi A, Costanzo R, Catalano G, Bianco AR, De Placido S. Carlomagno C, et al. Among authors: ferrara c. Oncology. 2002;63(3):219-25. doi: 10.1159/000065468. Oncology. 2002. PMID: 12381900 Clinical Trial.
Capecitabine plus weekly oxaliplatin in gastrointestinal tumors: a phase I study.
Carlomagno C, Orditura M, Pepe S, De Vita F, Romano C, Ciardiello F, Ferrara C, Martinelli E, Bianco R, Aurilio G, D'Agostino D, Tortora G, Catalano G, De Placido S. Carlomagno C, et al. Among authors: ferrara c. Am J Clin Oncol. 2006 Feb;29(1):85-9. doi: 10.1097/01.coc.0000195087.24930.e7. Am J Clin Oncol. 2006. PMID: 16462509 Clinical Trial.
The Effect of Vaccination against COVID-19 in Cancer Patients: Final Results of the COICA Trial.
Di Lorenzo G, Ingenito C, D'Ambrosio B, Ranieri C, Iuliucci MR, Iervolino M, Primiano F, Buonerba L, Busto G, Ferrara C, Libroia A, Ragone G, De Falco F, Costabile F, Fimiani P, Ugliano F, Leo E, Roviello G, Scafuri L, Buonerba C. Di Lorenzo G, et al. Among authors: ferrara c. Oncology. 2022;100(9):512-518. doi: 10.1159/000525962. Epub 2022 Jul 11. Oncology. 2022. PMID: 35817009 Free article.
The Impact of Routine Molecular Screening for SARS-CoV-2 in Patients Receiving Anticancer Therapy: An Interim Analysis of the Observational COICA Study.
Di Lorenzo G, Iervolino M, Primiano F, D'Ambrosio M, Ingenito C, Buonerba L, Busto G, Ferrara C, Libroia A, Ragone G, De Falco F, Costabile F, Fimiani P, Ugliano F, Ranieri C, Leo E, Roviello G, Scafuri L, Guerra G, Buonerba C. Di Lorenzo G, et al. Among authors: ferrara c. Oncology. 2022;100(9):505-511. doi: 10.1159/000521086. Epub 2021 Nov 26. Oncology. 2022. PMID: 34839299 Free article.
COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature.
Di Lorenzo G, Di Trolio R, Kozlakidis Z, Busto G, Ingenito C, Buonerba L, Ferrara C, Libroia A, Ragone G, Ioio CD, Savastano B, Polverino M, De Falco F, Iaccarino S, Leo E. Di Lorenzo G, et al. Among authors: ferrara c. Crit Rev Oncol Hematol. 2020 Aug;152:102991. doi: 10.1016/j.critrevonc.2020.102991. Epub 2020 May 21. Crit Rev Oncol Hematol. 2020. PMID: 32544802 Free PMC article.
Coronavirus Disease 2019 Emergency and Cancer in the South of Italy: What's New for the Oncologist?
Ingenito C, Buonerba L, Ferrara C, Busto G, Libroia A, Ragone G, Leo E, Savastano B, Ioio CD, De Falco F, Iaccarino S, Tarantino L, Polverino M, Di Lorenzo G. Ingenito C, et al. Among authors: ferrara c. Front Med (Lausanne). 2020 May 6;7:189. doi: 10.3389/fmed.2020.00189. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32435648 Free PMC article. No abstract available.
Faster cross-bridge detachment and increased tension cost in human hypertrophic cardiomyopathy with the R403Q MYH7 mutation.
Witjas-Paalberends ER, Ferrara C, Scellini B, Piroddi N, Montag J, Tesi C, Stienen GJ, Michels M, Ho CY, Kraft T, Poggesi C, van der Velden J. Witjas-Paalberends ER, et al. Among authors: ferrara c. J Physiol. 2014 Aug 1;592(15):3257-72. doi: 10.1113/jphysiol.2014.274571. Epub 2014 Jun 13. J Physiol. 2014. PMID: 24928957 Free PMC article.
The homozygous K280N troponin T mutation alters cross-bridge kinetics and energetics in human HCM.
Piroddi N, Witjas-Paalberends ER, Ferrara C, Ferrantini C, Vitale G, Scellini B, Wijnker PJM, Sequiera V, Dooijes D, Dos Remedios C, Schlossarek S, Leung MC, Messer A, Ward DG, Biggeri A, Tesi C, Carrier L, Redwood CS, Marston SB, van der Velden J, Poggesi C. Piroddi N, et al. Among authors: ferrara c. J Gen Physiol. 2019 Jan 7;151(1):18-29. doi: 10.1085/jgp.201812160. Epub 2018 Dec 21. J Gen Physiol. 2019. PMID: 30578328 Free PMC article.
HDAC6 contributes to pathological responses of heart and skeletal muscle to chronic angiotensin-II signaling.
Demos-Davies KM, Ferguson BS, Cavasin MA, Mahaffey JH, Williams SM, Spiltoir JI, Schuetze KB, Horn TR, Chen B, Ferrara C, Scellini B, Piroddi N, Tesi C, Poggesi C, Jeong MY, McKinsey TA. Demos-Davies KM, et al. Among authors: ferrara c. Am J Physiol Heart Circ Physiol. 2014 Jul 15;307(2):H252-8. doi: 10.1152/ajpheart.00149.2014. Epub 2014 May 23. Am J Physiol Heart Circ Physiol. 2014. PMID: 24858848 Free PMC article.
274 results